Judson G. T. Bemis

ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms

Jennifer D. Hintzsche, R. Doebele, A. Tan, 2017, Molecular Cancer Therapeutics.

MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML

A. Tan, W. Tse, Jianjun Chen, 2011, British journal of haematology.

Evidence for production of early pregnancy factor (Hsp10), microRNAs and exosomes by day 8 equine embryos

L. Bemis, R. Ferris, P. McCue, 2012 .

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma

N. Mukherjee, C. Amato, W. Robinson, 2018, Cell Death & Disease.

BRAF fusions identified in melanomas have variable treatment responses and phenotypes

M. McCarter, J. Tentler, T. Pitts, 2018, Oncogene.

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma

N. Mukherjee, C. Amato, W. Robinson, 2018, Cell Death & Disease.